PRESS RELEASE published on 02/26/2024 at 14:46, 8 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Currys plc The Vanguard Group discloses 4.37% stake in Currys plc. Form 8.3 filing under Takeover Code. Details of securities owned and derivatives dealt Securities Form 8.3 The Vanguard Group Takeover Code Currys Plc
BRIEF published on 02/26/2024 at 14:46, 8 months 23 days ago The Vanguard Group, Inc. reveals its position in Currys plc The Vanguard Group, Inc. Currys Plc Institutional Investment Shareholder Participation Stock Transaction
PRESS RELEASE published on 02/22/2024 at 15:06, 8 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Currys plc The Vanguard Group, Inc. discloses a 4.37% stake in Currys plc as of 21st Feb 2024. Details on securities and derivative transactions provided The Vanguard Group Inc. Financial Disclosure Stake Disclosure Securities Transactions Currys Plc
BRIEF published on 02/22/2024 at 15:06, 8 months 27 days ago The Vanguard Group, Inc. announces a significant position in Currys plc Shares Investment Takeover Code Currys Plc Vanguard
PRESS RELEASE published on 02/21/2024 at 15:51, 8 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Currys plc The Vanguard Group, Inc. disclosed an interest of 4.34% in Currys plc as of 20 Feb 2024. Details of ownership and positions revealed in Form 8.3 filing Securities The Vanguard Group, Inc. Form 8.3 Disclosure Currys Plc
BRIEF published on 02/21/2024 at 15:51, 8 months 28 days ago The Vanguard Group, Inc. Announces Position in Currys plc Shares The Vanguard Group, Inc. Finance Stake Currys Plc
BRIEF published on 02/20/2024 at 14:58, 9 months ago La Vanguard Group, Inc. Reveals its Stake in Currys plc Ordinary Shares Equity Stake Rule 8.3 La Vanguard Group, Inc. Currys Plc
PRESS RELEASE published on 02/20/2024 at 14:58, 9 months ago Form 8.3 - The Vanguard Group, Inc.: Currys plc The Vanguard Group, Inc. discloses a 4.31% stake in Currys plc as of 19 February 2024. Form 8.3 filing with relevant securities details Form 8.3 Relevant Securities The Vanguard Group Inc. Stake Disclosure Currys Plc
Published on 11/21/2024 at 13:30, 25 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 25 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 55 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 55 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 55 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 20 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 40 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 57 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 35 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 10 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo